CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives

Human & Experimental Toxicology
Blanca SinuésA Cebollada

Abstract

This study was performed to assess the influence of age, sex, smoking, and contraceptive use on CYP2A6 activity. In the metabolism of caffeine, the conversion of 1,7 dimethylxanthine (17X) to 1,7 dimethiylurate (17U) is catalyzed primarily by CYP2A6. CYP2A6 phenotype was determined by the urinary ratio 17U:17X in the interval of 4-5 h after caffeine intake in 179 healthy white Spaniards (102 women and 76 men). There were 99 non-smokers and 80 smokers. Among women, 26 were taking oral contraceptives. The age was the most important predictive factor of CYP2A6 activity (P < 0.001) with older subjects having higher activity. The influence of the gender was more modest (P = 0.07) with women exhibiting borderline increased values of the CYP2A6 marker than men. Tobacco smoking did not affect CYP2A6 activity. However, the CYP2A6 marker resulted to be strongly related to the use of oral contraceptives. The women users of oral contraceptives had higher values of CYP2A6 marker than both women not taking oral contraceptives and men (P < 0.001 in both comparisons). The results indicate that age, oral contraceptive use, and possibly gender should be controlled in epidemiological studies dealing with CYP2A6 activity and its relationship with ...Continue Reading

References

Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·T AoyamaF J Gonzalez
Aug 1, 1986·British Journal of Clinical Pharmacology·J O MinersD J Birkett
Nov 1, 1984·Clinical Pharmacology and Therapeutics·G P StoehrR B Smith
May 1, 1983·Clinical Pharmacology and Therapeutics·D M GrantW Kalow
Mar 1, 1996·Clinical Pharmacology and Therapeutics·K L SlayterW J Jusko
Jul 9, 1998·Nature·M L PianezzaR F Tyndale
Mar 27, 1999·Lancet·S J LondonG A Coetzee
May 21, 1999·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·S OinamM Chatterjee
Jun 3, 1999·Biochemical Pharmacology·S KoskelaH Raunio
Aug 12, 1999·Biochemical and Biophysical Research Communications·M MiyamotoT Kamataki
Apr 27, 2000·Toxicology·O PelkonenM Pasanen
Nov 10, 2000·International Journal of Clinical Pharmacology and Therapeutics·Y C BechtelP R Bechtel
Feb 24, 2001·International Journal of Clinical Pharmacology and Therapeutics·H LelouëtP R Bechtel
Apr 11, 2001·European Journal of Clinical Pharmacology·L Molander, E Lunell
Apr 19, 2002·Carcinogenesis·Zeki TopcuTetsuya Kamataki
Apr 19, 2002·The Journal of Pharmacology and Experimental Therapeutics·Delia DempseyNeal L Benowitz
Apr 27, 2002·Journal of Women's Health & Gender-based Medicine·M V ZemanE M Sellers
Aug 20, 2002·European Journal of Clinical Pharmacology·Ping XuHong-Hao Zhou
Aug 27, 2002·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·L HardellA Lilja
Mar 12, 2003·The Pharmacogenomics Journal·A Rautio
Mar 26, 2003·Toxicology in Vitro : an International Journal Published in Association with BIBRA·D F V LewisP S Goldfarb
Jun 28, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Miyuki KimuraTetsuya Kamataki
May 9, 2006·Clinical Pharmacology and Therapeutics·Neal L BenowitzPeyton Jacob
Sep 6, 2006·Clinical Pharmacology and Therapeutics·Miki NakajimaTsuyoshi Yokoi
Jan 24, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Eriko HigashiTsuyoshi Yokoi

❮ Previous
Next ❯

Citations

Jun 2, 2009·Molecular Pharmacology·David J Waxman, Minita G Holloway
Sep 21, 2013·The Journal of Antimicrobial Chemotherapy·Aline T MarinhoSofia A Pereira
Jan 2, 2014·Omics : a Journal of Integrative Biology·Eleni AklilluMagnus Ingelman-Sundberg
Jan 5, 2011·Expert Opinion on Drug Metabolism & Toxicology·Nikolaos KokrasZeta Papadopoulou-Daifoti
Jun 23, 2015·Drug Metabolism and Personalized Therapy·Ayorinde Adehin, Oluseye O Bolaji
Aug 2, 2012·Drug Metabolism and Pharmacokinetics·Natasa DjordjevicEleni Aklillu
Oct 21, 2016·Clinical Pharmacokinetics·Gail D Anderson, Lingtak-Neander Chan
Jun 21, 2011·The Journal of Nutritional Biochemistry·Xiaodong ZhouZhongtang Yu
Dec 18, 2019·International Journal of Toxicology·ChingYi Jennifer HsiehMartha S Sandy
Nov 6, 2012·Expert Review of Clinical Pharmacology·Janne Hukkanen
Dec 29, 2020·Drug Metabolism Reviews·Wojciech Kuban, Władysława Anna Daniel
Oct 29, 2020·Archives of Toxicology·Jukka HakkolaOlavi Pelkonen
Sep 2, 2017·Addictive Behaviors·Alicia M AllenMegan E Piper
May 19, 2021·Pharmacology Research & Perspectives·Shanna C TrenamanKerry Goralski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Susan NowellNicholas P Lang
Drug Metabolism and Pharmacokinetics
Natasa DjordjevicEleni Aklillu
© 2022 Meta ULC. All rights reserved